Crossmark

Examining the effect of evaluation sample size on the sensitivity and specificity of COVID-19 diagnostic tests in practice: a simulation study

Published Online: 2022-04-25

Published Print: 2022-12

Authors

Sammut-Powell, Camilla

Reynard, Charles https://orcid.org/0000-0002-7534-2668
Allen, Joy

McDermott, John

Braybrook, Julian

Parisi, Rosa

Lasserson, Daniel

Body, Richard

,

Body, Richard

Hayward, Gail

Allen, Joy

Braybrook, Julian

Buckle, Peter

Dark, Paul

Davis, Kerrie

Cook, Eloise

Gordon, Adam

Halstead, Anna

Lasserson, Dan

Lewington, Andrew

Nicholson, Brian

Perera-Salazar, Rafael

Simpson, John

Turner, Philip

Prestwich, Graham

Reynard, Charles

Riley, Beverley

Tate, Valerie

Wilcox, Mark
License Information

Text and Data Mining valid from 2022-04-25

Version of Record valid from 2022-04-25
More Information

Article History

Received: 6 July 2021

Accepted: 20 December 2021

First Online: 25 April 2022

Declarations

:

: The simulation study does not involve patients and as such does not require ethical approval. The Facilitating AcceLerated Clinical Validation Of Novel Diagnostics for COVID-19 study recruitment data is used to add context. This study was approved by National Research Ethics Service (reference 20/WA/0169).

: This is a simulation study and no patient data is used in the main analysis.

: Professor Richard Body has consulted for Siemens, Roche, Beckman, Singulex, LumiraDx and Abbott but not relating to COVID-19.

Document is current